麻豆AV

Respirology Presentations

New Asthma Guidelines

Graduated from 麻豆AV in 1975. Medical degree from Universit茅 Libre de Bruxelles in Belgium in 1983. Residency in Medicine and Respiratory Medicine at 麻豆AV 1984-1990. Director of the Asthma Clinic at the Montreal Chest Institute. Associate Professor of Medicine at 麻豆AV. Director of Respiratory In-Patient services at the MUHC. Research interests include critical care medicine and the pathophysiology of asthma.

听

Learning Objectives:

1. Understand what leads to poor control of asthma
2. Develop a plan to diagnose and follow progress of asthmatic patients in the clinic
3. Describe and explain the new Canadian asthma guidelines and GINA 2020 recommendations

Interstitial Lung Disease

Deborah Assayag completed her medical school and residency at 麻豆AV. She then went on to do a clinical and research fellowship in interstitial lung disease at the University of California San Francisco, along with a Masters in Epidemiology and Biostatistics. She is now an Assistant Professor at 麻豆AV in the Department of Medicine, and member of the Division of Respirology at the MUHC. She is a Scientist at the Research Institute MUHC. Her work focuses on disparities in care of patients with interstitial lung diseases.

听

Learning Objectives:

1. Understand what interstitial lung diseases are
2. Recognize common challenges with diagnosis
3. Understand the approach to management in most cases

Tackling Sleep Apnea: Diagnosis

Dr Kimoff is Professor of Medicine in the Respiratory Division, Department of Medicine at the 麻豆AV Health Center. He is medical director of the MUHC Clinical Sleep Laboratory and the MUHC Research Institute Sleep Research facility. His clinical practice involves respiratory medicine and multi-disciplinary sleep disorders. His academic activities include diverse teaching responsibilities and a clinically-oriented research program on sleep-disordered breathing including: 1) innovative diagnostic and therapeutic strategies; 2) upper airway neuromuscular dysfunction and inflammation; and 3) cardiometabolic and reproductive health, with current studies in congestive heart failure and adverse effects of maternal sleep apnea on pregnancy outcomes.

Learning Objectives:

1. Describe the clinically relevant pathophysiology of OSA: causes and complications
2. Describe the prevalence of OSA and key OSA symptoms
3. Describe the approaches and to and indications for sleep apnea testing

Tackling Sleep Apnea: Treatment

Scientist, RI-MUHC
Translational Research in Respiratory Diseases Program
Centre for Outcomes Research and Evaluation

Associate Professor, Department of Medicine, Faculty of Medicine and Health Sciences, 麻豆AV, Department of Medicine, Division of Respiratory Medicine, MUHC.听Her research focuses on the cardiometabolic consequences of sleep apnea in the general population and in pregnancy and has been involved in clinical epidemiological studies. She is also interested in the treatment implications of sleep apnea in order to improve health outcomes through randomized controlled trials.

Learning Objectives:

1. Identify key lifestyle changes that can be used to help treat OSA
2. State the outcomes that are improved with the use of continuous positive airway pressure (CPAP)
3. Identify the main strategies that can be used to improve CPAP adherence
4. Recognize that there are alternative treatment options to CPAP, depending on the phenotype of the patient鈥檚 OSA

Pharmacotherapy and COPD

Dr. Bryan Ross is a Respirologist at the 麻豆AV Health Centre and an Assistant Professor at 麻豆AV. He completed his medical school and residency at the University of Toronto and his Respirology fellowship at the University of Alberta. He then completed a COPD and Pulmonary Rehabilitation fellowship at the Montreal Chest Institute/麻豆AV, and is currently completing an accelerated M.Sc. in Epidemiology at 麻豆AV. Prior to his medical training he completed his undergraduate degree at Queen鈥檚 University and his master鈥檚 degree in Physiology at 麻豆AV. His clinical and research interests include COPD, pulmonary rehabilitation, respiratory and cardiac physiology and applied exercise science.

Learning Objectives:

1. Present the latest guideline updates on the pharmacological management of COPD 2.
2. Personalize inhaled pharmacologic therapy regimens for COPD, using the specific and unique clinical features of the patient
3. Conceptualize inhaler therapies as central within the pharmacological management of COPD; and of pharmacological treatments as one of many pillars within the framework of the comprehensive and multidisciplinary care of COPD

Air Quality and the Lungs

Maxime Cormier is a respirologist at MUHC, and Assistant professor at 麻豆AV. He completed his training in respirology at 麻豆AV, followed by a fellowship in Occupational lung diseases and Asthma at Universit茅 de Montr茅al. He is also the site program director for the 麻豆AV Internal Medicine residency training program for the Royal Victoria Hospital. His clinial interests include occupational lung diseases, asthma and sarcoidosis.

听

Learning Objectives:

1. Understand how outdoor air quality is associated with development and worsening of respiratory diseases
2. Recognize how indoor air quality may affect lung diseases
3. Discuss the risks of radon and mold/fungus exposure in the development of lung diseases
4. Appreciate the diversity of personal protective respirators used in the workplace
5. Recognize the steps in the assessment of a patient with possible work-related asthma

Post COVID Follow-Up of Respiratory Symptoms

Dr. Jennifer Landry joined the MUHC Respiratory Division in 2005, after an FRQS-funded research fellowship in cystic fibrosis in Cardiff, Wales. She then obtained her MSc degree in Epidemiology at 麻豆AV studying the long-term outcome of preterm births. She has held operating grants from CIHR and FRQS, examining lung function and quality of life among survivors of preterm birth. She co-founded the PATROL (Pediatric to Adult TRansition and Orphan Lung disease) clinic with Dr. Arnold Kristof. Her clinical practice focuses on cystic fibrosis, lung disease of prematurity, and other rare pulmonary diseases. She also holds key administrative posts, including the medical directorship of the Montreal Chest Institute outpatient clinics, and formerly the Royal Victoria Hospital site directorship for the core Internal Medicine residency training program. She is the medical director of the respiratory medicine post-COVID clinic at the Montreal Chest Institute.

Learning Objectives:

1. Recognize the most common respiratory manifestations following a SARS-CoV-2 infection
2. Investigate some of the most common pulmonary sequalae of a SARS-CoV-2 infection and manage them accordingly
3. Identify which subset of patients need to be referred to subspecialists for more advanced investigations and management